← Leaderboards
Shih-Yuan Liu
University Of Oregon
$5,032,609
Attributed
$5,159,824
Total exposure
4
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $513.3K · FY2010–25$1M$750K$500K$250K$0
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$5,159,824 · 4
By mechanism
R01$4,130,393 · 2
R35$775,000 · 1
R41$254,431 · 1
Top collaborators
- Donald Allen Upson1 shared
Others in their field
Top investigators on “Boron”
- James C Hone · California Institute Of Technology$17,703,522
- Robert A. Bonomo · Louis Stokes Cleveland Va Medical Center$8,871,189
- F D Toste · University Of California Berkeley$7,987,094
- Gary A Molander · University Of Pennsylvania$6,964,140
- Steven Armen Boyd · Venatorx Pharmaceuticals, Inc.$6,328,779
- James Patrick Morken · University Of North Carolina Chapel Hill$6,300,381
Research focus
BoronNitrogenBiomedical ResearchSynthesis ChemistryDesignProgramsPreparationExhibitsBiologicalInvestigationStructureChemistryProteinsLigandsGenerationsCarbonFamilyBaseMuramidasePositioning AttributeEngineeringDrug DevelopmentPharmacophoreBiology
Grant awards (19)
Expanding the Chemical and Functional Space with Boron-Nitrogen Heterocycles$387,500
R35 · FY2025 · GM · contact PI
Expanding the Chemical and Functional Space with Boron-Nitrogen Heterocycles$387,500
R35 · FY2024 · GM · contact PI
Novel Reagents and Catalysts for Organic Synthesis$328,650
R01 · FY2023 · GM · contact PI
Novel Reagents and Catalysts for Organic Synthesis$328,650
R01 · FY2022 · GM · contact PI
Novel Reagents and Catalysts for Organic Synthesis$328,650
R01 · FY2021 · GM · contact PI
Novel Reagents and Catalysts for Organic Synthesis$60,133
R01 · FY2021 · GM · contact PI
Novel Reagents and Catalysts for Organic Synthesis$328,650
R01 · FY2020 · GM · contact PI
Development of BN Heterocycles for Biomedical Research$328,650
R01 · FY2019 · GM · contact PI
Development of BN Heterocycles for Biomedical Research$328,650
R01 · FY2018 · GM · contact PI
Development of BN Heterocycles for Biomedical Research$328,650
R01 · FY2017 · GM · contact PI
Development of BN Heterocycles for Biomedical Research$230,525
R01 · FY2016 · GM · contact PI
Development of BN Heterocycles for Biomedical Research$98,126
R01 · FY2016 · GM · contact PI
Development of BN Heterocycles for Biomedical Research$94,742
R01 · FY2016 · GM · contact PI
Development of BN Heterocycles for Biomedical Research$294,377
R01 · FY2014 · GM · contact PI
Development of BN Heterocycles for Biomedical Research$284,074
R01 · FY2013 · GM · contact PI
Development of BN Heterocycles for Biomedical Research$258,239
R01 · FY2012 · GM · contact PI
Development of BN Heterocycles for Biomedical Research$258,819
R01 · FY2011 · GM · contact PI
Novel Azaborine Derivatives Predicted to Eliminate Acetaminophen Hepatotoxicity$254,431
R41 · FY2011 · GM · contact PI
Development of BN Heterocycles for Biomedical Research$250,808
R01 · FY2010 · GM · contact PI